Immunomodulation in the critically ill
Immunotherapy in the critically ill is an appealing notion because of the apparent abnormal immune and inflammatory responses seen in so many patients. The administration of a medication that could alter immune responses and decrease mortality in patients with sepsis could represent a ‘magic bullet’...
Saved in:
Published in | British journal of anaesthesia : BJA Vol. 103; no. 1; pp. 70 - 81 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
01.07.2009
Oxford University Press Oxford Publishing Limited (England) British Journal of Anaesthesia. Published by Elsevier Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Immunotherapy in the critically ill is an appealing notion because of the apparent abnormal immune and inflammatory responses seen in so many patients. The administration of a medication that could alter immune responses and decrease mortality in patients with sepsis could represent a ‘magic bullet’. Various approaches have been tried over the last 20 yr: steroids; anti-endotoxin or anti-cytokine antibodies; cytokine receptor antagonists; and other agents with immune-modulating side-effects. However, in some respects, research along these lines has been unsuccessful or disappointing at best. The current state of knowledge is summarized with particular reference to sepsis and the acute respiratory distress syndrome. |
---|---|
Bibliography: | ark:/67375/HXZ-08KDGBND-T istex:DD723223B1E1594F4FFD2E7A377FB7542ACC0706 ArticleID:aep128 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0007-0912 1471-6771 |
DOI: | 10.1093/bja/aep128 |